Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-19-059645)

Filing Details

Accession Number:: 0001104659-19-059645
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-04 19:04:44
Reporting Period:: 2019-11-04

Accepted Time:: 2019-11-04 19:04:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720725	Oyster Point Pharma Inc.	OYST	Biological Products, (No Disgnostic Substances) (2836)	811030955

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724489	Vida Ventures, Llc	40 Broad Street, Suite 201 Boston MA 02109		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	778,468	$0.00	778,468	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	185,000	$16.00	963,468	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series B Convertible Preferred Stock	Disposition	2019-11-04	778,468	$0.00	778,468	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.